Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders

Drug Development Research

Volumn 67, Issue 8, 2006, Pages 651-665

  Malmlöf, Kjell ^a   Hohlweg, Rolf ^a   Rimvall, Karin ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Food intake; H3 receptor antagonists; Histamine; Obesity

Indexed keywords

2 (3 TRIFLUOROMETHYLPHENYL)HISTAMINE; 5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN; A 331440; AGOUTI RELATED PROTEIN; ALPHA FLUOROMETHYLHISTIDINE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPHENIRAMINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CONESSINE; GLUCAGON LIKE PEPTIDE; GSK 189254; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; INSULIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; NEUROTRANSMITTER; NN 382238; NNC 381049; NNC 381202; THIOPERAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UCL 1972; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNINDEXED DRUG;

ARCUATE NUCLEUS; BODY FAT; BODY WEIGHT; BRAIN LEVEL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; INSULIN SENSITIVITY; LIPID OXIDATION; METABOLIC DISORDER; MOUSE; NERVE PROJECTION; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PERIKARYON; RAT; REGULATORY MECHANISM; REVIEW; RHESUS MONKEY; SATIETY; SWINE; THALAMUS MIDLINE NUCLEUS; ZONA INCERTA;

EID: 33845255034     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20140     Document Type: Review

References (120)

1. Arrang J, Garbarg M, Schwartz J. 1983. Auto inhibition of brain histamine release mediated by a novel class of H-3 of histamine receptor. Nature (Lond) 302:832-837.
2. Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. 1987. Highly potent and selective ligands for histamine H3-receptors. Nature 327:117-123.
3. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311.
4. Baptista T, Zarate J, Joober R, Colasante C, Beaulieu S, Paez X, Hernandez L. 2004. Drug induced weight gain, an impediment to successful pharmacotherapy: Focus on antipsychotics. Curr Drug Targets 5:279-299.
5. Berken GH, Weinstein DO, Stern WC. 1984. Weight gain. A side-effect of tricyclic antidepressants. J Affect Disord 7:133-138.
6. Bjenning C, Juul A-G, Lange KZ, Rimvall K. 2001. Peripherally administered ciproxifan elevates hypothalamic histamine levels and potently reduces food intake in the Sprague Dawley rat. In: Watanabe T, Timmennan H, Yanai K, editors. Histamine research in the new millennium. Amsterdam: Elsevier. p 449-450.
7. Bjenning CA, Rimvall K. 2000. oCRF and CRF (6-33) depress food but not water intake in the obese Zucker rat. International J Obes 24:8140-5141.
8. Brown RE, Stevens DR, Haas HL. 2001. The physiology of brain histamine. Progr Neurobiol 63:637-672.
9. Celanire S, Wijtmans M, Talaga P, Leurs R, De Esch IJP. 2005. Histamine H-3 receptor antagonists reach out for the clinic. Drug Discov Today 10:1613-1627.
10. Clineschmidt BV, Lotti VJ. 1973. Histamine: intraventricular injection suppresses ingestive behavior of the cat. Arch Int Pharmacodyn Ther 206:288-298.
11. Cowart M, Sun M, Zhao C, Witte DG, Miller TR, Krueger KM, Browman K, Fox GB, Esbenshade TA, Hancock AA. 2006. A new family of histamine H3 receptor antagonists based on a natural product: discovery, development of SAR, and properties of the series. Abstract at 35th Annual Meeting of the European Histamine Research Society, Delphi, Greece.
12. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD. 1999. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 24:155-163.
13. Cowley MA, Smart JL, Rubinstein M, Cordan MG, Diano S, Horvath TL, Cone RD, Low MJ. 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484.
14. Delany JP, Hansen BC, Bodkin NL, Hannah J, Bray GA, Leibel RL. 1999. Long-term calorie restriction reduces energy expenditure in aging monkeys. J Gerontol Ser A Biol Sci Med Sci 54:B5-B13.
15. D'Este L, Wimalawansa SJ, Renda TG. 2001. Distribution of amylin-immunoreactive neurons in the monkey hypothalamus and their relationships with the histaminergic system. Arch Histol Cytol 64:295-303.
16. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. 1998. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395:535-547.
17. Fekete C, Liposits Z. 2003. Histarnine-immunoreactive neurons of the tuberomammillary nucleus are innervated by alpha-melanocyte stimulating hormone-containing axons. Generation of a new histamine antiserum for ultrastructural studies. Brain Res 969:70-77.
18. Finer N. 2002. Pharmacotherapy of obesity. Best Pract Res Clin Endocr Metab 16:717-742.
19. Finkelstein EA, Fiebelkorn IC, Wang GJ. 2004. State-level estimates of annual medical expenditures attributable to obesity. Obes Res 12:18-24.
20. Flier JS, Harris M, Hollenberg AN. 2000. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest 105:859-861.
21. Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, Yamada T. 1991a. Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178:1386-1392.
22. Gantz I, Schaffer M, DelValle J, Logsdon C, Campbell V, Uhler M, Yamada T. 1991b. Molecular Cloning of a Gene Encoding the Histamine H2 Receptor. Proc Natl Acad Sci USA 88:429-433.
23. Garbarg M, Barbin G, Rodergas E, Schwartz JC. 1980. Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem 35:1045-1052.
24. Goldstein DJ, Rampey AH, Bray GA, Gray D. 1991. Fluoxetine treatment of obese patients with noninsulin dependent diabetes mellitus. Clin Res 39:767A.
25. Gotoh K, Fukagawa K, Fukagawa T, Noguchi H, Kakuma T, Sakata T, Yoshimatsu H. 2005. Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior. FASEB J 19:1131-1133.
26. Haas H, Panula P. 2003. The role of histamine and the tubero-mamillary nucleus in the nervous system. Nat Rev Neurosci 4:121-130.
27. Hadden DR, Blair AL, Wilson EA, Boyle DM, Atkinson AB, Kennedy AL, Buchanan KD, Merrett JD, Montgomery DA, Weaver JA. 1986. Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Q J Med 59:579-598.
28. Håkansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. 1998. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18:559-572.
29. Halford JC. 2006. Pharmacotherapy for obesity. Appetite 46:6-10.
30. 3 antagonists/inverse agonists. Biochem Pharmacol 71:1103-1113.
31. Hancock AA, Brune ME. 2005. Assessment of pharmacology and potential anti-obesity properties of H-3 receptor antagonists/inverse agonists. Expert Opin Invest Drugs 14:223-241.
32. Hancock AA, Esbenshade TA, Krueger KM, Yao BB. 2003. Genetic and pharmacological aspects of histamine H-3 receptor heterogeneity. Life Sci 73:3043-3072.
33. Hancock AA, Bennani YL, Bush EN, Esbenshade TA, Faghih R, Fox GB, Jacobson P, Knourek-Segel V, Krueger KM, Nuss ME, Pan JB, Shapiro R, Witte DG, Yao BB. 2004. Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. Eur J Pharmacol 487:183-197.
34. Harder H, Dinesen B, Astrup A. 2004. The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 28:180-182.
35. Hatton GI, Yang QZ. 2001. Ionotropic histamine receptors and H-2 receptors modulate supraoptic oxytocin neuronal excitability and dye coupling. J Neurosci 21:2974-2982.
36. Honrubia MA, Vilaro MT, Palacios JM, Mengod G. 2000. Distribution of the histamine H2 receptor in monkey brain and its mRNA localization in monkey and human brain. Synapse (New York) 38:343-354.
37. Horak F, Stubner UP. 1999. Comparative tolerability of second generation antihistamines. DRUG SAF 20:385-401.
38. Hough LB. 2001. Genomics meets histamine receptors: New subtypes, new receptors. Mol Pharmacol 59:415-419.
39. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. 2001. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790-797.
40. Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H. 1988. Organization of histaminergic fibers in the rat brain. J Comp Neurol 273:283-300.
41. Itoh Y, Oishi R, Saeki K. 1991. Feeding-induced increase in the extracellular concentration of histamine in rat hypothalamus as measured by in vivo microdialysis. Neurosci Lett 125:235-237.
42. Itowi N, Nagai K, Nakagawa H, Watanabe T, Wada H. 1988. Changes in the feeding behavior of rats elicited by histamine infusion. Physiol Behav 44:221-226.
43. Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI. 2003. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46:3957-3960.
44. Jansen FP, Mochizuki T, Yamamoto Y, Timmerman H, Yamatodani A. 1998. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application. Eur J Pharmacol 362:149-155.
45. Kalucy RS. 1981. Drug-induced weight gain. Current Therapy 22:127-140.
46. Karlstedt K, Senkas A, Ahman M, Panula P. 2001. Regional expression of the histamine H(2) receptor in adult and developing rat brain. Neuroscienc 102:201-208.
47. Kasaoka S, Tsuboyama-Kasaoka N, Kawahara Y, Inoue S, Tsuji M, Ezaki O, Kato H, Tsuchiya T, Okuda H, Nakajima S. 2004. Histidine supplementation suppresses food intake and fat accumulation in rats. Nutrition 20:991-996.
48. Kraus T, Zimmermann U, Schuld A, Haack M, Hinze-Selch D, Pollmacher T. 2001. On the pathophysiology of weight regulation during treatment with psychotropic drugs. Forschritte Neurol Psychiatr 69:116-137.
49. Lamberty Y, Margineanu DG, Dassesse D, Klitgaard H. 2003. H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the rat. Pharmacol Res 48:193-198.
50. Lau F, Bekker Jeppesen C, Rimvall K, Hohlweg R. 2006. Ureas with histamine H3-antagonist receptor activity - A new scaffold discovered by lead-hopping from cinnamic acid amides. Bioorg & Med Chem Letters 16:5303-5308.
51. Lecklin A, Tuomisto L. 1995. Fluid balance in rats of three different strains after inhibition of histamine catabolism. Physiol Behav 58:861-867.
52. 1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism. Pharmacol Biochem Behav 59:753-758.
53. Lecklin A, Etuseppala P, Stark H, Tuomisto L. 1998. Effects of intracerebroventricularly infused histamine and selective h-1, h-2 and h-3 agonists on food and water-intake and urine flow in wistar rats. Brain Res 793:279-288.
54. Leibel RL, Rosenbaum M, Hirsch J. 1995. Changes in energy expenditure resulting from altered body weight. N Engl J Med 332:621-628.
55. Leurs R, Bakker RA, Timmerman H, De Esch IJP. 2005. The histamine H-3 receptor: From gene cloning to H-3 receptor drugs. Nat Rev Drug Discov 4:107.
56. Lovenberg TW, Roland BL, Wilson SJ, Jiang XX, Pyati J, Huvar A, Jackson MR, Erlander MG. 1999. Cloning and functional expression of the human histamine H-3 receptor. Mol Pharmacol 55:1101-1107.
57. Lovenberg TW, Pyati J, Chang H, Wilson SJ, Erlander MG. 2000. Cloning of rat histamine H-3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293:771-778.
58. Lutz TA, Del Prete E, Walzer B, Scharrer E. 1996. The histaminergic, but not the serotoninergic, system mediates amylin's anorectic effect. Peptides 17:1317-1322.
59. Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HHF, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K. 2005. Influence of a selective histamine H-3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes 29:1402-1412.
60. Malmlöf K, Peschke B, Golozoubova V, Cremers T, Wulf BS, Johansen P, Rimvall K. 2006. Pharmacological targeting of the central histamine H3 receptor alters body weight homeostasis, lipid metabolism and insulin action in a rat model of diet induced obesity. Obesity Research, in press.
61. Masaki T, Yoshimatsu H. 2006. The hypothalamic H-1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity. Trends Pharmacol Sci 27:279-284.
62. Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T. 2001. Targeted disruption of histamine H-1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes 50:385-391.
63. Masaki T, Chiba S, Yoshimichi G, Yasuda T, Noguchi H, Kakuma T, Sakata T, Yoshimatsu H. 2003. Neuronal histamine regulates food intake, adiposity, and uncoupling protein expression in agouti yellow (Ay/a) obese mice. Endocrinology 144:2741-2748.
64. Mercer LP, Kelley DS, Humphries LL, Dunn JD. 1994. Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. J Nutr 124:1029-1036.
65. Mollet A, Lutz TA, Meier S, Riediger T, Rushing PA, Scharrer E. 2001. Histamine H-1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 281:R1442-R1448.
66. Mollet A, Meier S, Riediger T, Lutz TA. 2003. Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin. Peptides 24:155-158.
67. Morimoto T, Yamamoto Y, Mobarakeh JI, Yanai K, Watanabe T, Yamatodani A. 1999. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 67:679-683.
68. Nelson DL, Gehlert DR. 2006. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29:49-60.
69. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. 2000. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781-36786.
70. Ookuma K, Yoshimatsu H, Sakata T, Fujimoto K, Fukagawa K. 1989. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res 490:268-275.
71. Ookuma K, Sakata T, Fujimoto K. 1990. Evidence for feeding elicited through antihistaminergic effects of tricyclic antidepressants in the rat hypothalamus. Psychopharmacology 101:481-485.
72. Ookuma K, Sakata T, Fukagawa K, Yoshimatsu H, Kurokawa M, Machidori H, Fujimoto K. 1993. Neuronal histamine in the hypothalamus suppresses food-intake in rats. Brain Res 628:235-242.
73. Orthen-Gambill N. 1988. Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats. Pharmacol Biochem Behav 31:81-86.
74. Palacios JM, Wamsley JK, Kuhar MJ. 1981. The distribution of histamine H1-receptors in the rat brain: an autoradiographic study. Neuroscience 6:15-37.
75. Panula P, Yang HYT, Costa E. 1984. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572-2576.
76. Panula P, Pirvola U, Auvinen S, Airaksinen MS. 1989. Histamine- immunoreactive nerve fibers in the rat brain. Neuroscience 28:585-610.
77. Paxinos G, Chai SY, Christopoulos G, Huang XF, Toga AW, Wang HQ, Sexton PM. 2004. In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat 27:217-236.
78. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. 2003. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138:24-32.
79. Peschke B, Bak S, Hohlweg R, Pettersson I, Refsgaard HHF, Viuff D, Rimvall K. 2004. Cinnamic amides of (S)-2-(aminomethyl)-pyrrolidines are potent H-3 antagonists. Biol Med Ch 12:2603-2616.
80. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM. 2002. A detailed mapping of the histamine H-3 receptor and its gene transcripts in rat brain. Neuroscience 114:173-193.
81. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L, MacLean LD, Sugerman HJ, Mason E. 1995. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-352.
82. Reda TK, Geliebter A, Pi-Sunyer FX. 2002. Amylin, food intake, and obesity. Obes Res 10:1087-1091.
83. Reiner PB, Heimrich B, Keller F, Haas HL. 1988. Organotypic culture of central histamine neurons. Brain Res 442:166-170.
84. Rimvall K, Peschke B, Cremers TIFH, Westerink BHC, Wulff BS, Golozoubova V, Johansen PB, Refsgaard HHF, Malmlöf K. 2004. Body-weight lowering effects of the cinnamic amide, NNC 0038-0000-1202, a novel histamine H3 receptor antagonist, in obese rodents. 33rd Annual Meeting of the European Histamine Research Society, 2004, Düsseldorf/Cologne, Germany.
85. 2 -receptor gene. Biochem Biophys Res Commun 179:1470-1478.
86. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL, Woods SC. 2001. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142:5035-5038.
87. Sakata T, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, Wada H. 1988a. Feeding induced by blockade of histamine H1-receptor in rat brain. Experientia 44:216-218.
88. Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A, Wada H. 1988b. Modulation of neuronal histamine in control of food intake. Physiol Behav 44:539-543.
89. Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, Wada H. 1988c. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res 441:403-407.
90. Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A, Wada H. 1990. Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Res 537:303-306.
91. Sander LE, Lorentz A, Sellge G, Coeffier M, Neipp M, Veres T, Frieling T, Meier PN, Manns MP, Bischoff SC. 2006. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut 55:498-504.
92. Schlicker E, Malinowska B, Kathmann M, Gothert M. 1994. Modulation of neurotransmitter release via histamine h-3 heteroreceptors. Fundamental and Clinical Pharmacology 8:128-137.
93. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. 2000. Central nervous system control of food intake. Nature 404:661-671.
94. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. 1994. In-vitro autoradiographic localization of amylin binding-sites in rat-brain. Neuroscience 62:553-567.
95. Sheiner JB, Morris P, Anderson GH. 1985. Food intake suppression by histidine. Pharmacol Biochem Behav 23:721-726.
96. Silver RB, Mackins CJ, Smith NCE, Koritchneva IL, Lefkowitz K, Lovenberg TW, Levi R. 2001. Coupling of histamine H-3 receptors to neuronal Na+/H+ exchange: A novel protective mechanism in myocardial ischemia. Proc Natl Acad Sci USA 98:2855-2859.
97. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104:531-043.
98. Stark H. 2003. Recent advances in histamine H-3/H-4 receptor ligands. Expert Opin Therapeut Patents 13:851-865.
99. Stark H, Sadek B, Krause M, Huls A, Ligneau X, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. 2000. Novel histamine H-3-receptor antagonists with carbonyl- substituted 4-(3-(phenoxy) propyl)-1H-imidazole structures like ciproxifan and related compounds. J Med Chem 43:3987-3994.
100. Takahashi K, Suwa H, Ishikawa T, Kotani H. 2002. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110:1791-1799.
101. Tamiya R. 1991. Synaptic inputs to histaminergic neurons in the rat posterior hypothalamus. Osaka City Med J 37:107-122.
102. Tamiya R, Hanada M, Narita N, Kawai Y, Tohyama M, Takagi H. 1989. Neuropeptide Y afferents have synaptic interactions with histaminergic (histidine decarboxylase-immunoreactive) neurons in the rat brain. Neurosci Lett 99:241-245.
103. Tamiya R, Hanada M, Narita N, Inagaki S, Tohyama M, Takagi H. 1990. Histaminergic neurons receive substance P-ergic inputs in the posterior hypothalamus of the rat. Exp Brain Res 79:261-265.
104. Toftegaard CL, Knigge U, Kjaer A, Warberg J. 2003. The role of hypothalamic histamine in leptin-induced suppression of short-term food intake in fasted rats. Regul Pept 111:83-90.
105. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. 2004. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 27:155-161.
106. Tsuda K, Yoshimatsu H, Niijima A, Chiba S, Okeda T, Sakata T 2002. Hypothalamic histamine neurons activate lipolysis in rat adipose tissue. Exp Biol Med 227:208-213.
107. van der Goot H, Timmerman H. 2000. Selective ligands as tools to study histamine receptors. Eur J Med Chem 35:5-20.
108. Van Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vincken W. 1997. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 10:2216-2224.
109. Varty LM, Gustafson E, Laverty M, Hey JA. 2004. Activation of histamine H-3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 484:83-89.
110. Vaziri P, Dang K, Anderson GH. 1997. Evidence for histamine involvement in the effect of histidine loads on food and water intake in rats. J Nutr 127:1519-1526.
111. Wada H, Inagaki N, Yamatodani A, Watanabe T. 1991. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 14:415-418.
112. Watanabe T, Taguchi Y, Shiosaka S, et al. 1984. Distribution of the histaminergic neuron system in the central nervous system of rats: A fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295:13-25.
113. Whyment AD, Blanks AM, Lee K, Renaud LP, Spanswick D. 2006. Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H-1 receptors. J Neurophysiol 95:2492-2500.
114. Yamashita M, Fukui H, Sugama K, Horio Y, Ito S, Mizuguchi H, Wada H. 1991. Expression Cloning of a cDNA Encoding the Bovine Histamine H1 Receptor. Proc Natl Acad Sci USA 88:11515-11519.
115. Yasuda T, Masaki T, Chiba S, Kakuma T, Sakata T, Yoshimatsu H. 2004. L-Histidine stimulates sympathetic nerve activity to brown adipose tissue in rats. Neurosci Lett 362:71-74.
116. Yoshimatsu H. 2006. The neuronal histamine H-1 and pro-opiomelanocortin- melanocortin 4 receptors: Independent regulation of food intake and energy expenditure. Peptides 27:326-332.
117. Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T. 1999. Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48:2286-2291.
118. Yoshimatsu H, Chiba S, Tajima D, Akehi Y, Sakata T. 2002. Histidine suppresses food intake through its conversion into neuronal histamine. Exp Biol Med 227:63-68.
119. Zaragoza F, Stephensen H, Knudsen SM, Pridal L, Wulff BS, Rimvall K. 2004. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H-3 receptor antagonists. J Med Chem 47:2833-2838.
120. Zhu Y, Michalovich D, Wu HL, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li XT, Herrity NC, Vawter L, Sarau HM, Ames RS, Davenport BM, Hieble JP, Wilson S, Bergsma DJ, Fitzgerald LR. 2001. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59:434-441.